Find clinical trials for Triple Negative Breast Cancer in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Indianapolis, IN, USA:
and to evaluate the efficacy of this combination in advanced HER2 negative breast cancer that is triple negative...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 4 other locations
of care (SOC) chemotherapy monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple...
Phase 2
Indianapolis, Indiana, United States and 3 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Indianapolis, Indiana, United States of America and 224 other locations
levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple...
Phase 2
Indianapolis, Indiana, United States and 62 other locations
Researchers are looking for new ways to treat types of breast cancer that are both:* High-risk, which means the cancer may ...
Phase 3
Indianapolis, Indiana, United States and 23 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...
Phase 1
Indianapolis, Indiana, United States and 29 other locations
The primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors w...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 8 other locations
including metastatic colorectal cancer (mCRC) patients....
Phase 1
Indianapolis, Indiana, United States and 38 other locations
This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 12 other locations
in participants with locally advanced or metastatic solid tumors harboring a TP53 Y220C mutation. The Phase 1 portion of the study will asse...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 83 other locations
Clinical trials
Research sites
Resources
Legal